Chemoinformaics analysis of 24-Methylenepollinastanol
| Molecular Weight | 412.702 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 23 |
| Exact Molecular Weight | 412.371 | nRing | 5 |
| Solubility: LogS | -6.774 | nHRing | 0 |
| Solubility: LogP | 6.488 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 1 | BPOL | 48.1539 |
| QED | 0.457 |
| Synth | 5.467 |
| Natural Product Likeliness | 3.517 |
| NR-PPAR-gamma | 0.28 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.033 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.872 |
| MDCK | 0.0000144 |
| BBB | 0.695 |
| PPB | 0.995586 |
| VDSS | 1.43 |
| FU | 0.0198419 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.607 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.115 |
| CYP2c9-sub | 0.364 |
| CYP2d6-inh | 0.119 |
| CYP2d6-sub | 0.854 |
| CYP3a4-inh | 0.483 |
| CYP3a4-sub | 0.649 |
| CL | 15.439 |
| T12 | 0.016 |
| hERG | 0.053 |
| Ames | 0.046 |
| ROA | 0.112 |
| SkinSen | 0.788 |
| Carcinogencity | 0.06 |
| EI | 0.059 |
| Respiratory | 0.574 |
| NR-Aromatase | 0.256 |
| Antiviral | No |
| Prediction | 0.62716 |